Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroGen

0.2859
-0.0004-0.14%
Volume:457.69K
Turnover:132.61K
Market Cap:28.85M
PE:-0.60
High:0.3005
Open:0.2951
Low:0.2806
Close:0.2863
Loading ...

FGEN Enhances Treasury with Share Purchase

TIPRANKS
·
17 Apr

FibroGen Announces Publication of Results From Phase 1 Monotherapy Study of FG-3246 in Patients With Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

THOMSON REUTERS
·
28 Mar

FibroGen Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
19 Mar

FibroGen Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Mar

Q4 2024 FibroGen Inc Earnings Call

Thomson Reuters StreetEvents
·
18 Mar

FibroGen Announces Strategic Sale and Financial Outlook

TIPRANKS
·
18 Mar

FibroGen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

FibroGen Q4 EPS From Continuing Operations $(0.08), Revenue From Continuing Operations $3.100M

Benzinga
·
18 Mar

FibroGen Inc: Qtrly Net Income per Share $0.18

THOMSON REUTERS
·
18 Mar

FibroGen options imply 18.1% move in share price post-earnings

TIPRANKS
·
18 Mar

FibroGen Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
15 Mar

FGEN Enhances Share Capital Management with Treasury Share Purchase

TIPRANKS
·
05 Mar

BRIEF-FibroGen Says Entered ATM Equity Offering Sales Agreement Relating To Sale From Time To Time Of Shares Of Common Stock

Reuters
·
25 Feb

FibroGen Inc - Entered Atm Equity Offering Sales Agreement Relating to Sale From Time to Time of Shares of Common Stock

THOMSON REUTERS
·
25 Feb

FGEN Enhances Shareholder Value with Strategic Share Repurchase

TIPRANKS
·
24 Feb

AstraZeneca Buys FibroGen China for $160 Million to Gain Access to Anemia Drug

MT Newswires Live
·
21 Feb

BUZZ-FibroGen soars on $160 mln China unit sale to AstraZeneca

Reuters
·
20 Feb

FibroGen sells China unit to AstraZeneca in deal worth $160 million

Reuters
·
20 Feb

BRIEF-Fibrogen Announces Sale Of Fibrogen China To Astrazeneca For About $160 Million

Reuters
·
20 Feb

FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

THOMSON REUTERS
·
20 Feb